Premier Research Polandsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2002-06-06
Share capital
50,000.00 PLN
Average employment (FTE)
116 (2025)
Registered address
Puławska 303, 02-785 Warszawa, Poland
Electronic delivery address
AE:PL-12426-88564-HUUEA-12
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $19,810 | |
| Profit allocation | Retained in reserve capital | |
| Capital expenditure | $46,791 | |
| Planned capital expenditure (next year) | $62,783 | |
| Foreign sales | 100% of revenue ($12,244,080) | |
| Revenue structure | Sprzedaż usług |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 489 days for 2021). All were audited by a statutory auditor.
- 202509/07/2026
- 202401/10/2025
- 202330/09/2024
- 202220/05/2024
- 202116/11/2023
- 202020/12/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Research and experimental development in natural sciences and engineering18 / 277
Top 6.5%
Results vs industry
Revenue
This companyUSD 12.27mMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD 18.10kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 12.48mMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 10.61mMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Mariesa Beth Coppola – Management Board Member
Katarzyna Łepecka Czajkowska – Attorney-in-fact (sole)
Joanna Katarzyna Eineberg – Attorney-in-fact (sole)
Richard William Shimota – President of the Management Board
Manner of representation
Each member of the management board may represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Premier Research Germany Ltd | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1999-02-08.
46 1140 1010 0000 2661 3700 1002
73 1140 1010 0000 2661 3700 1001
88 1280 0003 0000 0031 7305 1021
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 4,571PLN 4,571 |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pit-RadwarS.A. | $204,620,378.98 | pitradwar.com | ||
| GenomedS.A. | $7,373,750.46 | genomed.pl | ||
| Agencja Rynku EnergiiS.A. | $2,676,821.15 | are.waw.pl | ||
| Fluence Technologysp. z o.o. | $2,486,673.06 | fluence.pl | ||
| Oncotransfersp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Smart FluidS.A. | $681,963.98 | smartfluid.pl | ||
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com |
Change history
| Date | Event | |
|---|---|---|
| 2008-04-09 | Address change (Jubilerska 10, 04-190, Warszawa → Puławska 303, 02-785, Warszawa) | |
| 2006-08-28 | Name change (Imform Polska → "premier Research Poland") | |
| 2004-07-08 | Address change (Afrykańska 2, 03-966, Warszawa → Jubilerska 10, 04-190, Warszawa) | |
| 2003-12-08 | Share capital increase (4,000.00 PLN → 50,000.00 PLN) | |
| 2002-06-06 | Entered in the register |
FAQ
The main business activity of Premier Research Poland focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on June 6, 2002.
The headquarters is located at: Puławska 303, 02-785 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 12,271,829, representing a decrease of 34.2% compared to 2024.
Yes, the company recorded a net profit of USD 18,097 in 2025, meaning the company decreased its profit by 98.6%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 7,120,163 in 2025, representing 57% of all operating expenses.
Last updated: 2026-10-07